[VRDN] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 27.01%
YoY- 33.22%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 1,451 828 372 4,784 462 818 645 14.45%
PBT -18,460 -8,044 -11,629 -4,661 -6,980 -2,758 -2,634 38.29%
Tax 55 27 339 167 30 0 0 -
NP -18,460 -8,044 -11,629 -4,661 -6,980 -2,758 -2,634 38.29%
Tax Rate - - - - - - - -
Total Cost 19,911 8,872 12,001 9,445 7,442 3,576 3,279 35.03%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -1,272.23 -971.50 -3,126.08 -97.43 -1,510.82 -337.16 -408.37 20.83%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -2.91 -2.65 -5.65 -2.64 -9.06 -3.85 -6.82 -13.22%
EPS Diluted -2.91 -2.65 -5.65 -2.64 -9.06 -3.85 -6.82 -13.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.